Streetbeat News

Analyst Ratings

BLUE

bluebird bio (NASDAQ:BLUE) reported Q2 earnings per share of $(0.67), beating the analyst consensus estimate of $(0.72) by 6.94%. However, the company's quarterly sales of $6.89 million missed the analyst consensus estimate of $9.31 million by 25.99%. Despite the sales miss, this represents a 353.59% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:36 am

NRGV

Energy Vault Holdings (NYSE:NRGV) reported Q2 losses of $(0.18) per share, beating the analyst consensus estimate of $(0.20) by 10 percent. However, the company's quarterly sales of $39.68 million missed the analyst consensus estimate of $55.30 million by 28.25 percent.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:36 am

PLTR

Raymond James analyst Brian Gesuale has maintained an 'Outperform' rating on Palantir Technologies (NYSE:PLTR) and raised the price target from $18 to $22.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 11:35 am

STIM

Neuronetics (NASDAQ:STIM) reported Q2 earnings per share of $(0.17), beating the analyst consensus estimate of $(0.35) by 51.43%. This is a 56.41% increase over losses from the same period last year. The company also reported quarterly sales of $17.61 million, beating the analyst consensus estimate of $17.38 million by 1.32%, a 7.84% increase over sales from the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 08, 2023 | 11:34 am

AYX

Needham analyst Mike Cikos maintains a Buy rating on Alteryx (NYSE:AYX) but lowers the price target from $55 to $35.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 11:30 am

LCID

Needham analyst Chris Pierce maintains a Buy rating on Lucid Group (NASDAQ:LCID) but lowers the price target from $10 to $9.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 11:28 am

CARA

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Cara Therapeutics (NASDAQ:CARA) and maintained a price target of $22.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 11:28 am

RNG

Needham analyst Ryan Koontz maintains a Buy rating on RingCentral (NYSE:RNG) and raises the price target from $42 to $46.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 11:27 am

ACVA

Needham analyst Chris Pierce has reiterated a 'Buy' rating on ACV Auctions (NASDAQ:ACVA) and maintained a price target of $23.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 11:26 am

QQQ

SPY

US stocks are expected to pull back due to inflation anxieties. The earnings news flow is likely to drive the market, with oil's pullback and upcoming US inflation data keeping the mood cautious. Analysts from LPL Financial suggest a mild recession is likely within the next six to nine months. They recommend a neutral tactical allocation to equities, favoring developed international equities over emerging markets and large caps over small caps. In premarket trading, the SPDR S&P 500 ETF Trust and the Invesco QQQ ETF fell. Several companies including Lucid Group, Paramount Global, Chegg, Beyond Meat, Eli Lilly, Fox Corp, Expeditors International of Washington, GlobalFoundries, Novavax, UPS, Warner Music Group, Akamai Technologies, Rivian Automotive, Twilio, Upstart Holdings, and Lyft are in focus due to their earnings reports.

Portfolio Pulse from Shanthi Rexaline

August 08, 2023 | 11:26 am